Nchi: Australia
Lugha: Kiingereza
Chanzo: Department of Health (Therapeutic Goods Administration)
levocetirizine dihydrochloride, Quantity: 5 mg
UCB Australia Pty Ltd T/A UCB Pharma Division of UCB Australia
levocetirizine dihydrochloride
Tablet, film coated
Excipient Ingredients: colloidal anhydrous silica; microcrystalline cellulose; lactose monohydrate; magnesium stearate; titanium dioxide; hypromellose; macrogol 400
Oral
1, 28, 30, 2, 10, 7
(S2) Pharmacy Medicine
Xyzal tablets are indicated for the symptomatic treatment of allergic rhinitis (including persistent allergic rhinitis) and chronic idiopathic urticaria.
Visual Identification: White to off white, oval film-coated tablet with Y logo on one side.; Container Type: Blister Pack; Container Life Time: 5 Years; Container Temperature: Store below 30 degrees Celsius
Licence status A
2008-03-06